Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Treatment Study for Patients with Glioblastoma

This study is currently closed to enrollment.

Testing the use of the immunotherapy drugs ipilimumab and nivolumab plus radiation therapy compared to the usual treatment (temozolomide and radiation therapy) for newly diagnosed MGMT unmethylated Glioblastoma

Glioblastoma brain cancer, CT scan
AGE: ≥ 18 years old
TYPE: Interventional Study
CONDITION: Glioblastoma
LOCATION: UH Cleveland Medical Center or Virtual

Study Purpose

The purpose of this study is to compare the usual treatment with radiation therapy and temozolomide to radiation therapy in combination with immunotherapy with ipilimumab and nivolumab in treating patients with newly diagnosed MGMT unmethylated glioblastoma.

Study ID